Definitive Contract 75N93022C00031
Award Date
7/1/22
Potential Completion Date
6/30/23
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Vitruvian Bio, LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Daniels, MD 21043, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
9
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $299,968 firm-fixed-price SBIR Phase I contract to Vitruvian Bio, LLC, a small disadvantaged, woman-owned business, to develop an electrochemical self-monitoring device for rapid nucleic acid-based testing of HIV-1. This contract, which has a completion date of July 31, 2025, is set aside for small businesses and is part of NIAID's efforts to support the research and development of innovative diagnostic...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a "SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS" project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...
This federal contract award, valued at $224,562.96, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health (NIH). The contract was awarded to Infotech Soft, Inc., a for-profit, woman-owned business, and is a Definitive Contract with a Firm Fixed Price. The work is to be performed in Miami, Florida and the contract has a completion date of July 31, 2018. This appears to be a...
This is a $585,350 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Virtici LLC, a small business limited liability company, to develop a novel adjuvant-based probiotic platform for generating tolerance therapeutics. The contract is part of the Small Business Innovation Research (SBIR) Program Phase I initiative. Virtici has extensive experience in federal biomedical research and development contracts and...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This is a $1,500,000.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services, to Cure Systems LLC, a self-certified small disadvantaged business located in Newton, Massachusetts. The contract is for the research and development of "Vector-Based Delivery of HIV Broadly Neutralizing Antibodies," a specialized approach to developing advanced...
<p>This is a $299,777.00 Firm Fixed Price contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Cure Systems LLC, a self-certified small disadvantaged business. The contract is for a SBIR Program Phase I action research project to be performed in Cambridge, MA. The contract has a set-aside designation for small businesses.</p>